PPARG and breast carcinoma: Moreover, a novel synthetic PPARγ ligand, the triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), was found to lower the tumor growth of MDA-MB-435 breast cancer cells implanted in nude mice [130].